Reaction Details Report a problem with these data
Target
Protein M2-1
Ligand
BDBM295009
Substrate
n/a
Meas. Tech.
Antiviral Assay
EC50
>10000±n/a nM
Citation
 Gomtsian, A; Dekhtyar, T; Frank, KE; Friedman, MM; Josephsohn, N; Molla, M; Vasudevan, A; Ng, IC; Chafeev, M Substituted cyanoguanidines as oral anti-virals US Patent  US10112911 Publication Date 10/30/2018 
Target
Name:
Protein M2-1
Synonyms:
Envelope-associated 22 kDa protein | M2-1 | M21_HRSVA | Matrix M2-1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
22163.59
Organism:
Human respiratory syncytial virus A (strain A2)
Description:
P04545
Residue:
194
Sequence:
MSRRNPCKFEIRGHCLNGKRCHFSHNYFEWPPHALLVRQNFMLNRILKSMDKSIDTLSEISGAAELDRTEEYALGVVGVLESYIGSINNITKQSACVAMSKLLTELNSDDIKKLRDNEELNSPKIRVYNTVISYIESNRKNNKQTIHLLKRLPADVLKKTIKNTLDIHKSITINNPKESTVSDTNDHAKNNDTT
  
Inhibitor
Name:
BDBM295009
Synonyms:
2-cyano-1-(2-methylphenyl)-3-[3-methyl-1-(quinoxalin-2-ylamino)butan-2-yl]guanidine | US10112911, Example 2.1
Type:
Small organic molecule
Emp. Form.:
C22H25N7
Mol. Mass.:
387.4808
SMILES:
CC(C)C(CNc1cnc2ccccc2n1)N\C(Nc1ccccc1C)=N/C#N
Structure:
Search PDB for entries with ligand similarity: